newsfilter
← Latest News
GlobeNewswire·

Iterum Therapeutics launches ORLYNVAH™, the first and only oral penem antibiotic in the U.S.

DUBLIN and CHICAGO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (NASDAQ:ITRM), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant